188 related articles for article (PubMed ID: 36348234)
21. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
22. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
23. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
24. Progressive multifocal leukoencephalopathy and other forms of JC virus disease.
Brew BJ; Davies NW; Cinque P; Clifford DB; Nath A
Nat Rev Neurol; 2010 Dec; 6(12):667-79. PubMed ID: 21131916
[TBL] [Abstract][Full Text] [Related]
25. [Neurological complications of JC virus infection: A review].
Moulignier A; Lecler A
Rev Med Interne; 2021 Mar; 42(3):177-185. PubMed ID: 33168355
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report.
Cifci B; Yildiz Y; Altin E; Habibi H; Kocer B; Dizbay M
J Neurovirol; 2023 Feb; 29(1):111-115. PubMed ID: 36795262
[TBL] [Abstract][Full Text] [Related]
27. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
28. Advances in Treatment of Progressive Multifocal Leukoencephalopathy.
Bernard-Valnet R; Koralnik IJ; Du Pasquier R
Ann Neurol; 2021 Dec; 90(6):865-873. PubMed ID: 34405435
[TBL] [Abstract][Full Text] [Related]
29. JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.
Wang X; Chen J; Gong J; Wu Y; Liu XH
BMC Neurol; 2022 Dec; 22(1):462. PubMed ID: 36494784
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
[TBL] [Abstract][Full Text] [Related]
31. Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis.
Barritt AW; Das E; Morley N; Seymour M; Saha R; Vera J; Vundavalli S; Dizdarevic S; Nicholas R; Berger JR; Fisniku LK
Mult Scler; 2023 Feb; 29(2):301-306. PubMed ID: 36451581
[TBL] [Abstract][Full Text] [Related]
32. A 41-year-old female with progressive multifocal leukoencephalopathy after liver transplant.
Ahmadinejad Z; Talebi F; Yazdi NA; Ghiasvand F
J Neurovirol; 2019 Aug; 25(4):605-607. PubMed ID: 31140129
[TBL] [Abstract][Full Text] [Related]
33. Immunology of progressive multifocal leukoencephalopathy.
Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
[TBL] [Abstract][Full Text] [Related]
34. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
35. Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.
Takahashi K; Sekizuka T; Fukumoto H; Nakamichi K; Suzuki T; Sato Y; Hasegawa H; Kuroda M; Katano H
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795410
[TBL] [Abstract][Full Text] [Related]
36. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.
Du Pasquier RA; Clark KW; Smith PS; Joseph JT; Mazullo JM; De Girolami U; Letvin NL; Koralnik IJ
J Neurovirol; 2001 Aug; 7(4):318-22. PubMed ID: 11517410
[TBL] [Abstract][Full Text] [Related]
37. The effect of plasma exchange on serum anti-JC virus antibodies.
Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
[TBL] [Abstract][Full Text] [Related]
38. Progressive multifocal leukoencephalopathy or immune reconstitution inflammatory syndrome after fingolimod cessation? A case report.
Mickeviciene D; Baltusiene A; Afanasjeva B; Afanasjevas D; Gleizniene R; Rastenyte D; Berger JR
BMC Neurol; 2022 Aug; 22(1):306. PubMed ID: 35986243
[TBL] [Abstract][Full Text] [Related]
39. Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Trentalange A; Calcagno A; Ghisetti V; Atzori C; Busolli P; Bonora S; Imperiale D
Antivir Ther; 2016; 21(7):633-635. PubMed ID: 26857363
[TBL] [Abstract][Full Text] [Related]
40. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
